Pricing Log in Create free account

Atea Pharmaceuticals, Inc. (AVIR) vs Kyverna Therapeutics, Inc. (KYTX)

Atea Pharmaceuticals, Inc. and Kyverna Therapeutics, Inc. are both Biotechnology companies. Atea Pharmaceuticals, Inc. and Kyverna Therapeutics, Inc. are of similar size ($369.2M and $363.3M). Across the 9 metrics below, Atea Pharmaceuticals, Inc. leads on 6 and Kyverna Therapeutics, Inc. on 3.

Valuation

Metric AVIR KYTX Biotechnology median
P/E n/m n/m 8.50
P/S 0.98 n/m 9.71
P/B 1.69 2.09 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 0.36 n/m 9.21
Earnings yield (48.15%) (51.85%) (33.15%)
Free cash flow yield (159.02%) (46.04%) (25.50%)

Profitability

Metric AVIR KYTX Biotechnology median
Gross margin 0.00% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (58.14%) (87.24%) (56.36%)
Return on assets (52.99%) (68.40%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric AVIR KYTX Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 3.00% (9.31%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric AVIR KYTX Biotechnology median
Debt to equity 0.00 0.15 0.00
Current ratio 8.13 9.06 4.72
Net debt to EBITDA 1.63 1.51 0.96

Dividend

Metric AVIR KYTX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric AVIR KYTX Biotechnology median
Market cap 363.33m 369.21m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack